Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharma-Bio Serv Inc (PBSV)

Pharma-Bio Serv Inc (PBSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Pharma-Bio Serv, Inc. provides consulting solutions to the pharmaceutical, chemical, medical device and biotechnology industries. Its services include regulatory compliance, validation, technology transfer, engineering, project management, process support, web pages, portals development, digital art design, intranets, extranets, software development, microbiological testing services, chemical testing services and technical trainings/seminars. The company operates in the U.S, Ireland and Spain. Pharma-Bio Serv, Inc. is headquartered in Dorado, Puerto Rico.

Fiscal Year End Date: 10/31

(Values in U.S. Thousands) Oct, 2024 Oct, 2023 Oct, 2022 Oct, 2021 Oct, 2020
Sales 9,510 16,980 19,400 20,120 21,560
Sales Growth -43.99% -12.47% -3.58% -6.68% +10.51%
Net Income -780 1,310 1,010 -2,090 2,050
Net Income Growth -159.54% +29.70% +148.33% -201.95% -1.91%
(Values in U.S. Thousands) Oct, 2024 Oct, 2023 Oct, 2022 Oct, 2021 Oct, 2020
Total Assets 16,290 19,900 20,650 23,920 29,920
Total Assets Growth -18.14% -3.63% -13.67% -20.05% +12.35%
Total Liabilities 2,580 3,780 4,090 5,010 7,200
Total Liabilities Growth -31.75% -7.58% -18.36% -30.42% +19.40%
(Values in U.S. Thousands) Oct, 2024 Oct, 2023 Oct, 2022 Oct, 2021 Oct, 2020
Operating Cash Flow -570 1,890 590 800 1,530
Operating Cash Flow Growth -130.16% +220.34% -26.25% -47.71% +169.23%
Net Cash Flow -3,680 -4,020 -3,010 330 1,650
Change in Net Cash Flow +8.46% -33.55% -1,012.12% -80.00% +405.56%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar